INSERM U1060, CarMeN Laboratory, Claude Bernard Lyon 1 University, F-69373 Lyon, France; Hospices Civils de Lyon, Hôpital Louis Pradel, Service d'Explorations Fonctionnelles Cardiovasculaires & CIC de Lyon, F-69394 Lyon, France.
INSERM U1060, CarMeN Laboratory, Claude Bernard Lyon 1 University, F-69373 Lyon, France.
J Mol Cell Cardiol. 2015 Jul;84:61-9. doi: 10.1016/j.yjmcc.2015.03.017. Epub 2015 Apr 11.
How ischemic postconditioning can inhibit opening of the mitochondrial permeability transition pore (PTP) and subsequent cardiac myocytes death at reperfusion remains unknown. Recent studies have suggested that de-acetylation of cyclophilin D (CyPD) by sirtuin 3 (SIRT3) can modulate its binding to the PTP.
The aim of the present study was to examine whether ischemic postconditioning (PostC) might activate SIRT3 and consequently prevent lethal myocardial reperfusion injury through a deacetylation of CyPD.
Using hypoxia-reoxygenation (H/R) in H9C2 cells, we showed that SIRT3 overexpression prevented CyPD acetylation, limited PTP opening and reduced cell death by 24%. In vitro modification of the CyPD acetylation status in MEFs by site-directed mutagenesis altered capacity of PTP opening by calcium. Calcium Retention Capacity (CRC) was significantly decreased with CyPD-KQ that mimics acetylated protein compared with CyPD WT (871 ± 266 vs 1193 ± 263 nmoles Ca(2+)/mg protein respectively). Cells expressing non-acetylable CyPD mutant (CyPD-KR) displayed 20% decrease in cell death compared to cells expressing CyPD WT after H/R. Correspondingly, in mice we showed that cardiac ischemic postconditioning could not reduce infarct size and CyPD acetylation in SIRT3 KO mice, and was unable to restore CRC in mitochondria as it is observed in WT mice.
Our study suggests that the increased acetylation of CyPD following myocardial ischemia-reperfusion facilitates PTP opening and subsequent cell death. Therefore ischemic postconditioning might prevent lethal reperfusion injury through an increased SIRT3 activity and subsequent attenuation of CyPD acetylation at reperfusion.
尚不清楚缺血后处理(PostC)如何抑制再灌注时线粒体通透性转换孔(PTP)的开放和随后的心肌细胞死亡。最近的研究表明,SIRT3 可以通过去乙酰化环孢素 D(CyPD)来调节其与 PTP 的结合。
本研究旨在探讨缺血后处理(PostC)是否可以通过 CyPD 的去乙酰化作用激活 SIRT3,从而防止致命的心肌再灌注损伤。
我们使用 H9C2 细胞中的缺氧-复氧(H/R),表明 SIRT3 过表达可防止 CyPD 乙酰化,限制 PTP 开放,并使细胞死亡减少 24%。在 MEFs 中通过定点突变改变 CyPD 乙酰化状态的体外修饰改变了钙诱导的 PTP 开放能力。与 CyPD WT(871 ± 266 与 1193 ± 263 nmoles Ca2+/mg 蛋白)相比,模拟乙酰化蛋白的 CyPD-KQ 使钙保留容量(CRC)显著降低(分别为 871 ± 266 与 1193 ± 263 nmoles Ca2+/mg 蛋白)。与表达 CyPD WT 的细胞相比,表达不可乙酰化 CyPD 突变体(CyPD-KR)的细胞在 H/R 后细胞死亡减少 20%。相应地,在小鼠中,我们发现心肌缺血后处理不能减少 SIRT3 KO 小鼠的梗死面积和 CyPD 乙酰化,并且不能像在 WT 小鼠中那样恢复再灌注时的 CRC。
我们的研究表明,心肌缺血再灌注后 CyPD 的乙酰化增加促进了 PTP 的开放和随后的细胞死亡。因此,缺血后处理可能通过增加 SIRT3 活性和随后减轻再灌注时 CyPD 乙酰化来防止致命的再灌注损伤。